Literature DB >> 6659213

Evaluation of cytostatic drug concentrations in the kidney, bladder wall, and prostate by means of the diffusion chamber technique in dogs.

P Porpaczy, C P Schmidbauer, A Georgopoulos, H Rameis, T A Endler.   

Abstract

The usefulness of a diffusion chamber model for measurement of concentrations of cytostatics in the interstitial fluid of tissues was tested. Chambers (pore size of the membranes: 0.45 mcm) were implanted in the kidney, bladder wall, and prostate of dogs. The concentrations after application of Doxorubicin-hydrochloride (2 mg/kg body wt.) and high doses of Methotrexate (100 mg/kg body wt.) were measured simultaneously and continuously in serum and in the above organs. The investigations showed that knowledge of the plasma level alone does not permit a prediction of the concentrations in the organs to be made. The diffusion chamber technique proved itself to be relatively simple to perform, economical, and it provides reproducible values.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6659213     DOI: 10.1007/BF00272282

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  23 in total

1.  What is interstitial fluid? Biochemical and physiological analysis of fluid obtained from tissue cages.

Authors:  H U Eickenberg
Journal:  Scand J Infect Dis Suppl       Date:  1978

2.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

Review 3.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Doxorubicin pharmacokinetics--the effects of protein deprivation.

Authors:  D P Kapelanski; J M Daly; E M Copeland; S J Dudrick
Journal:  J Surg Res       Date:  1981-04       Impact factor: 2.192

Review 5.  Pharmacokinetics of tissue penetration of antibiotics.

Authors:  T Bergan
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Rapid plasma clearance and reduced rate and extent of urinary elimination of parenterally administered methotrexate as a result of severe vomiting and diarrhoea.

Authors:  H W Van Den Berg; R F Murphy; D G Kennedy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.

Authors:  E Piazza; M G Donelli; M Broggini; C Sessa; N Natale; L Ottolenghi; S Marsoni; A Libretti; C Mangioni; L Morasca
Journal:  Cancer Treat Rep       Date:  1980 Aug-Sep

8.  Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration.

Authors:  Y T Lee; K K Chan; P A Harris; J L Cohen
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860

9.  Sorbent removal of adriamycin in vitro and in vivo.

Authors:  J F Winchester; A Rahman; W J Tilstone; A Kessler; L Mortensen; G E Schreiner; P S Schein
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

10.  Measurements of antimicrobial drug concentrations in renal interstitial fluid using the diffusion chamber technique.

Authors:  A Georgopoulos; E Schütze; G Laber
Journal:  Infection       Date:  1980       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.